資料搜尋諮詢服務
找不到您所需要的資料嗎?
我們能協助您找到最符合您研究需求的資訊
請撥打 +886-2-2799-3110
或透過電子郵件與我們聯絡 mi@hintoninfo.com
IHS_EWBIEEE xploreSTRATEGY ANALYTICSELSEVIERIHS_EWB_GF

頁面路徑選單

Electrotherapy Market —Forecast till 2027

  • LinkedIn
  • facebook
  • Twitter
出版日期:2021/08/01
頁  數:166頁
文件格式:PDF
價  格:
USD 4,450 (Single-User License)
USD 6,250 (Multi-User License)
線上訂購或諮詢
Electrotherapy Market—Forecast till 2027

Market Overview
The electrotherapy market is anticipated to record a healthy CAGR of 5.10% during the review period, to surpass USD 1,463.74 million by the end of 2027. The factors expected to propel the global market growth are the growing prevalence of sports injuries, technological advancements and new product launches, and rising healthcare expenditure.
The development of the electrotherapy market is driven by the innovative progressions in electrotherapy frameworks, expanding corpulence, rising number of sports wounds, and expanding medical services consumption are the main considerations driving the development of the worldwide electrotherapy market. Notwithstanding, the absence of mindfulness about the utilization of electrotherapy frameworks in non-industrial nations; accessibility of many substitutes; and immersion in created nations are upsetting the development of this market. Also, aside from public consumption of medical services, a few speculations by makers, financial speculators, and new items in the worldwide intracranial drain finding and therapy market are relied upon to drive the market development.
Market Segmentation
The electrotherapy market is classified into treatment type, device type, application, and end-user.
Based on treatment type, the market has been classified into extracorporeal shock wave therapy, interferential current therapy (IC), magnetic field therapy, ultrasound therapy, transcutaneous electrical nerve stimulation (TENS) therapy, micro-current therapy, transcutaneous spinal electro analgesia (TSE), pulsed short wave diathermy (PSWD), spinal cord stimulation (SCS), percutaneous electrical nerve stimulation (PENS), and others. Based on device type, the global electrotherapy market has been classified into transcutaneous electrical neural stimulator (TENS), electronic muscle stimulator (EMS), the interferential stimulator (IF), high voltage pulsed galvanic stimulator (HVPGS), microcurrent stimulator (MC), or microcurrent electrical neuromuscular stimulator (MENS), and others.
In terms of application the market has been categorized into pain management, neuromuscular dysfunction, urine and fecal incontinence, acute and chronic edema, tissue repair, iontophoresis, orthopedics, cardiology, and others. The pain management segment is again segmented into chronic pain, chronic fatigue, migraine headaches, wound healing, diabetic nerve pain, stimulating bone growth, and others.
Based on end-users the electrotherapy market is divided into hospitals & clinics, rehabilitation centers, long-term care centers, and others.
Regional Analysis
Geographically, the electrotherapy market, based on region, has been studied across the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas led the market in 2019 and is probably going to keep on directing during the appraisal time frame because of the set up medical services foundation, developing mindfulness identified with electrotherapy, and the presence of central members in the area.
The European electrotherapy market has been partitioned into Western Europe and Eastern Europe. The Western Europe electrotherapy market has additionally been arranged into Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. Europe would follow the Americas as far as worth during the figure time frame because of the expanding geriatric populace, the rising commonness of constant and way of life-related conditions, created medical care infrastructure, and high medical services spending.
Major players
The major players operating in global electrotherapy market are Medtronic plc (Ireland), Alimed, Inc (US), Cogentix Medical, Inc. (US), Jude Medical Inc. (US), Zynex Medical (US), DJO Global, Inc. (US), Livanova Plc (UK), Nervo Corp (US), Neuromextrix Inc. (US), and Boston Scientific Corporation (US)
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

2.5 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING INCIDENCE OF SPORTS INJURIES

4.2.2 TECHNOLOGICAL ADVANCEMENTS AND NEW PRODUCT LAUNCH

4.2.3 INCREASING HEALTHCARE EXPENDITURE

4.3 RESTRAINTS

4.3.1 LACK OF PHYSIOTHERAPISTS AND STRINGENT REGULATORY NORMS

4.4 OPPORTUNITIES

4.4.1 HIGH MARKET GROWTH TO SUPPORT NEW PRODUCT LAUNCH

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION AND SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 BARGAINING POWER OF SUPPLIERS

5.2.2 BARGAINING POWER OF BUYERS

5.2.3 THREAT OF NEW ENTRANTS

5.2.4 THREAT OF SUBSTITUTES

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE ELECTROTHERAPY MARKET

5.3.1 OVERVIEW

5.3.2 IMPACT ON SUPPLY CHAIN

5.3.3 IMPACT ON DEMAND FOR ELECTROTHERAPY

5.3.4 INCREASED ADOPTION OF ELECTROTHERAPY

6 GLOBAL ELECTROTHERAPY MARKET, BY TREATMENT TYPE

6.1 OVERVIEW

6.2 EXTRACORPOREAL SHOCK WAVE THERAPY

6.3 INTERFERENTIAL CURRENT THERAPY (IC)

6.4 MAGNETIC FIELD THERAPY

6.5 ULTRASOUND THERAPY

6.6 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) THERAPY

6.7 MICRO-CURRENT THERAPY

6.8 TRANSCUTANEOUS SPINAL ELECTRO ANALGESIA (TSE)

6.9 PULSED SHORT WAVE DIATHERMY (PSWD)

6.10 SPINAL CORD STIMULATION (SCS)

6.11 PERCUTANEOUS ELECTRICAL NERVE STIMULATION (PENS)

6.12 OTHERS

7 GLOBAL ELECTROTHERAPY MARKET, BY DEVICE TYPE

7.1 OVERVIEW

7.2 TRANSCUTANEOUS ELECTRICAL NEURAL STIMULATOR (TENS)

7.3 ELECTRONIC MUSCLE STIMULATOR (EMS)

7.4 INTERFERENTIAL STIMULATOR (IF)

7.5 HIGH VOLTAGE PULSED GALVANIC STIMULATOR (HVPGS)

7.6 MICROCURRENT STIMULATOR (MC) OR MICROCURRENT ELECTRICAL NEUROMUSCULAR STIMULATOR (MENS)

7.7 OTHERS

8 GLOBAL ELECTROTHERAPY MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 PAIN MANAGEMENT

8.3 NEUROMUSCULAR DYSFUNCTION

8.4 URINE AND FECAL INCONTINENCE

8.5 ACUTE AND CHRONIC EDEMA

8.6 TISSUE REPAIR

8.7 IONTOPHORESIS

8.8 ORTHOPAEDICS

8.9 CARDIOLOGY

8.10 OTHERS

9 GLOBAL ELECTROTHERAPY MARKET, BY END USERS

9.1 OVERVIEW

9.2 HOSPITALS & CLINICS

9.3 REHABILITATION CENTRES

9.4 LONG-TERM CARE CENTRES

9.5 OTHERS

10 GLOBAL ELECTROTHERAPY MARKET, BY REGION

10.1 OVERVIEW

10.2 AMERICAS

10.2.1 NORTH AMERICA

10.2.1.1 US

10.2.1.2 CANADA

10.2.2 LATIN AMERICA

10.3 EUROPE

10.3.1 WESTERN EUROPE

10.3.1.1 GERMANY

10.3.1.2 FRANCE

10.3.1.3 UK

10.3.1.4 ITALY

10.3.1.5 SPAIN

10.3.1.6 REST OF WESTERN EUROPE

10.3.2 EASTERN EUROPE

10.4 ASIA PACIFIC

10.4.1 CHINA

10.4.2 INDIA

10.4.3 JAPAN

10.4.4 SOUTH KOREA

10.4.5 AUSTRALIA

10.4.6 REST OF ASIA-PACIFIC

10.5 MIDDLE EAST & AFRICA

10.5.1 MIDDLE EAST

10.5.2 AFRICA

11 COMPETITIVE LANDSCAPE

11.1 OVERVIEW

11.2 COMPETITIVE BENCHMARKING

11.3 MAJOR GROWTH STRATEGY IN THE GLOBAL ELECTROTHERAPY MARKET

11.4 THE LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ELECTROTHERAPY MARKET

11.5 KEY DEVELOPMENT ANALYSIS

11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

11.6.1 PRODUCT LAUNCHES/PRODUCT APPROVALS

11.6.2 MERGERS/ACQUISITIONS

11.6.3 PARTNERSHIPS/AGREEMENTS

12 COMPANY PROFILES

12.1 MEDTRONIC PLC

12.1.1 COMPANY OVERVIEW

12.1.2 FINANCIAL OVERVIEW

12.1.3 PRODUCTS/SERVICES OFFERED

12.1.4 KEY DEVELOPMENTS

12.1.5 SWOT ANALYSIS

12.1.6 KEY STRATEGIES

12.2 ALIMED, INC.

12.2.1 COMPANY OVERVIEW

12.2.4 KEY DEVELOPMENTS

12.3 COGENTIX MEDICAL, INC.

12.3.1 COMPANY OVERVIEW

12.3.2 FINANCIAL OVERVIEW

12.3.3 PRODUCTS/SERVICES OFFERED

12.3.4 KEY DEVELOPMENTS

12.3.5 SWOT ANALYSIS

12.3.6 KEY STRATEGIES

12.4 ST. JUDE MEDICAL INC.

12.4.1 COMPANY OVERVIEW

12.4.2 FINANCIAL OVERVIEW

12.4.3 PRODUCTS OFFERED

12.4.4 KEY DEVELOPMENTS

12.4.5 SWOT ANALYSIS

12.4.6 KEY STRATEGIES

12.5 ZYNEX MEDICAL

12.5.1 COMPANY OVERVIEW

12.5.2 FINANCIAL OVERVIEW

12.5.3 PRODUCTS/SERVICES OFFERED

12.5.4 KEY DEVELOPMENTS

12.5.5 SWOT ANALYSIS

12.5.6 KEY STRATEGIES

12.6 DJO GLOBAL INC.

12.6.1 COMPANY OVERVIEW

12.6.4 KEY DEVELOPMENTS

12.7 LIVANOVA PLC

12.7.1 COMPANY OVERVIEW

12.7.2 FINANCIAL OVERVIEW

12.7.3 PRODUCTS/SERVICES OFFERED

12.7.4 KEY DEVELOPMENTS

12.7.5 SWOT ANALYSIS

12.7.6 KEY STRATEGIES

12.8 NEVRO CORP

12.8.1 COMPANY OVERVIEW

12.8.2 FINANCIAL OVERVIEW

12.8.3 PRODUCTS OFFERED

12.8.4 KEY DEVELOPMENTS

12.8.5 SWOT ANALYSIS

12.8.6 KEY STRATEGIES

12.9 NEUROMETRIX INC.

12.9.1 COMPANY OVERVIEW

12.9.2 FINANCIAL OVERVIEW

12.9.3 PRODUCTS/SERVICES OFFERED

12.9.4 KEY DEVELOPMENTS

12.9.5 SWOT ANALYSIS

12.9.6 KEY STRATEGIES

12.10 BOSTON SCIENTIFIC CORPORATION

12.10.1 COMPANY OVERVIEW

12.10.2 FINANCIAL OVERVIEW

12.10.3 PRODUCTS/SERVICES OFFERED

12.10.4 KEY DEVELOPMENTS

12.10.5 SWOT ANALYSIS

12.10.6 KEY STRATEGIES

13 APPENDIX

13.1 REFERENCES

13.2 RELATED REPORTS
回上頁